Could Pre-Surgery radiation stop liver cancer from coming back?
NCT ID NCT04587739
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests whether giving focused radiation to a liver tumor a few weeks before surgery is safe and practical. The goal is to kill microscopic cancer cells around the tumor that often cause the cancer to return after surgery. Thirty patients with a single liver cancer nodule will receive radiation followed by standard surgery, and researchers will monitor how many are unable to complete the planned surgery due to side effects or disease progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stereotactic body radiation therapy (SBRT)
- What this could lead to
- If successful, this approach could reduce the chance of liver cancer returning after surgery by destroying microscopic tumor cells around the main nodule.
- What could go wrong
- This is a very small, early-phase safety study with only 30 participants. The radiation could cause serious side effects or delay surgery, and it may not improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hop Claude Huriez Chu Lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cancer vaccine prime the body to better fight liver tumors?
- Training the immune system to hunt down leftover liver cancer cells
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Could a genetic marker guide future cancer therapies in taiwan?
- Can a tumor-zapping procedure also wake up the immune system?
- A machine that keeps donor livers alive outside the body — could it transform transplantation?